These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 27288483

  • 1. Ontogeny of SERT Expression and Antidepressant-like Response to Escitalopram in Wild-Type and SERT Mutant Mice.
    Mitchell NC, Gould GG, Koek W, Daws LC.
    J Pharmacol Exp Ther; 2016 Aug; 358(2):271-81. PubMed ID: 27288483
    [Abstract] [Full Text] [Related]

  • 2. Ontogeny of Norepinephrine Transporter Expression and Antidepressant-Like Response to Desipramine in Wild-Type and Serotonin Transporter Mutant Mice.
    Mitchell NC, Bowman MA, Gould GG, Koek W, Daws LC.
    J Pharmacol Exp Ther; 2017 Jan; 360(1):84-94. PubMed ID: 27831486
    [Abstract] [Full Text] [Related]

  • 3. Essential Contributions of Serotonin Transporter Inhibition to the Acute and Chronic Actions of Fluoxetine and Citalopram in the SERT Met172 Mouse.
    Nackenoff AG, Moussa-Tooks AB, McMeekin AM, Veenstra-VanderWeele J, Blakely RD.
    Neuropsychopharmacology; 2016 Jun; 41(7):1733-41. PubMed ID: 26514584
    [Abstract] [Full Text] [Related]

  • 4. The interaction of escitalopram and R-citalopram at the human serotonin transporter investigated in the mouse.
    Jacobsen JP, Plenge P, Sachs BD, Pehrson AL, Cajina M, Du Y, Roberts W, Rudder ML, Dalvi P, Robinson TJ, O'Neill SP, Khoo KS, Morillo CS, Zhang X, Caron MG.
    Psychopharmacology (Berl); 2014 Dec; 231(23):4527-40. PubMed ID: 24810106
    [Abstract] [Full Text] [Related]

  • 5. Altered response to the selective serotonin reuptake inhibitor escitalopram in mice heterozygous for the serotonin transporter: an electrophysiological and neurochemical study.
    Guiard BP, Mansari ME, Murphy DL, Blier P.
    Int J Neuropsychopharmacol; 2012 Apr; 15(3):349-61. PubMed ID: 21439106
    [Abstract] [Full Text] [Related]

  • 6. [Escitalopram: a selective inhibitor and allosteric modulator of the serotonin transporter].
    Mnie-Filali O, El Mansari M, Scarna H, Zimmer L, Sánchez C, Haddjeri N.
    Encephale; 2007 Dec; 33(6):965-72. PubMed ID: 18789789
    [Abstract] [Full Text] [Related]

  • 7. Antidepressant-like drug effects in juvenile and adolescent mice in the tail suspension test: Relationship with hippocampal serotonin and norepinephrine transporter expression and function.
    Mitchell NC, Gould GG, Smolik CM, Koek W, Daws LC.
    Front Pharmacol; 2013 Dec; 4():131. PubMed ID: 24191152
    [Abstract] [Full Text] [Related]

  • 8. Selective Serotonin Reuptake Inhibitors within Cells: Temporal Resolution in Cytoplasm, Endoplasmic Reticulum, and Membrane.
    Nichols AL, Blumenfeld Z, Luebbert L, Knox HJ, Muthusamy AK, Marvin JS, Kim CH, Grant SN, Walton DP, Cohen BN, Hammar R, Looger L, Artursson P, Dougherty DA, Lester HA.
    J Neurosci; 2023 Mar 29; 43(13):2222-2241. PubMed ID: 36868853
    [Abstract] [Full Text] [Related]

  • 9. NK1 receptor antagonism lowers occupancy requirement for antidepressant-like effects of SSRIs in the gerbil forced swim test.
    Lelas S, Li YW, Wallace-Boone TL, Taber MT, Newton AE, Pieschl RL, Davis CD, Molski TF, Newberry KS, Parker MF, Gillman KW, Bronson JJ, Macor JE, Lodge NJ.
    Neuropharmacology; 2013 Oct 29; 73():232-40. PubMed ID: 23770339
    [Abstract] [Full Text] [Related]

  • 10. Serotonin Transporter-Independent Actions of the Antidepressant Vortioxetine As Revealed Using the SERT Met172 Mouse.
    Nackenoff AG, Simmler LD, Baganz NL, Pehrson AL, Sánchez C, Blakely RD.
    ACS Chem Neurosci; 2017 May 17; 8(5):1092-1100. PubMed ID: 28272863
    [Abstract] [Full Text] [Related]

  • 11. Serotonin Transporter and Plasma Membrane Monoamine Transporter Are Necessary for the Antidepressant-Like Effects of Ketamine in Mice.
    Bowman MA, Vitela M, Clarke KM, Koek W, Daws LC.
    Int J Mol Sci; 2020 Oct 14; 21(20):. PubMed ID: 33066466
    [Abstract] [Full Text] [Related]

  • 12. In vivo imaging of serotonin transporter occupancy by means of SPECT and [123I]ADAM in healthy subjects administered different doses of escitalopram or citalopram.
    Klein N, Sacher J, Geiss-Granadia T, Attarbaschi T, Mossaheb N, Lanzenberger R, Pötzi C, Holik A, Spindelegger C, Asenbaum S, Dudczak R, Tauscher J, Kasper S.
    Psychopharmacology (Berl); 2006 Oct 14; 188(3):263-72. PubMed ID: 16955282
    [Abstract] [Full Text] [Related]

  • 13. Behavioral and serotonergic consequences of decreasing or increasing hippocampus brain-derived neurotrophic factor protein levels in mice.
    Deltheil T, Guiard BP, Cerdan J, David DJ, Tanaka KF, Repérant C, Guilloux JP, Coudoré F, Hen R, Gardier AM.
    Neuropharmacology; 2008 Nov 14; 55(6):1006-14. PubMed ID: 18761360
    [Abstract] [Full Text] [Related]

  • 14. Bacillus Calmette-Guérin vaccine induces a selective serotonin reuptake inhibitor (SSRI)-resistant depression like phenotype in mice.
    Vijaya Kumar K, Rudra A, Sreedhara MV, Siva Subramani T, Prasad DS, Das ML, Murugesan S, Yadav R, Trivedi RK, Louis JV, Li YW, Bristow LJ, Naidu PS, Vikramadithyan RK.
    Brain Behav Immun; 2014 Nov 14; 42():204-11. PubMed ID: 25016199
    [Abstract] [Full Text] [Related]

  • 15. Escitalopram, the S-(+)-enantiomer of citalopram, is a selective serotonin reuptake inhibitor with potent effects in animal models predictive of antidepressant and anxiolytic activities.
    Sánchez C, Bergqvist PB, Brennum LT, Gupta S, Hogg S, Larsen A, Wiborg O.
    Psychopharmacology (Berl); 2003 Jun 14; 167(4):353-62. PubMed ID: 12719960
    [Abstract] [Full Text] [Related]

  • 16. In vivo investigation of escitalopram's allosteric site on the serotonin transporter.
    Murray KE, Ressler KJ, Owens MJ.
    Pharmacol Biochem Behav; 2016 Feb 14; 141():50-7. PubMed ID: 26621784
    [Abstract] [Full Text] [Related]

  • 17. Serotonin clearance in vivo is altered to a greater extent by antidepressant-induced downregulation of the serotonin transporter than by acute blockade of this transporter.
    Benmansour S, Owens WA, Cecchi M, Morilak DA, Frazer A.
    J Neurosci; 2002 Aug 01; 22(15):6766-72. PubMed ID: 12151556
    [Abstract] [Full Text] [Related]

  • 18. Allosteric modulation of the effect of escitalopram, paroxetine and fluoxetine: in-vitro and in-vivo studies.
    Mansari ME, Wiborg O, Mnie-Filali O, Benturquia N, Sánchez C, Haddjeri N.
    Int J Neuropsychopharmacol; 2007 Feb 01; 10(1):31-40. PubMed ID: 16448580
    [Abstract] [Full Text] [Related]

  • 19. Blockade of the high-affinity noradrenaline transporter (NET) by the selective 5-HT reuptake inhibitor escitalopram: an in vivo microdialysis study in mice.
    Nguyen HT, Guiard BP, Bacq A, David DJ, David I, Quesseveur G, Gautron S, Sanchez C, Gardier AM.
    Br J Pharmacol; 2013 Jan 01; 168(1):103-16. PubMed ID: 22233336
    [Abstract] [Full Text] [Related]

  • 20. Transgenic elimination of high-affinity antidepressant and cocaine sensitivity in the presynaptic serotonin transporter.
    Thompson BJ, Jessen T, Henry LK, Field JR, Gamble KL, Gresch PJ, Carneiro AM, Horton RE, Chisnell PJ, Belova Y, McMahon DG, Daws LC, Blakely RD.
    Proc Natl Acad Sci U S A; 2011 Mar 01; 108(9):3785-90. PubMed ID: 21282638
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.